C12Y 301/30
Endoribonucleases active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters
Official title: Endoribonucleases active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters (3.1.30)
C12Y301/30 (Endoribonucleases active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters) appears on 16 US grants and 38 published applications in this corpus.
Search patents in C12Y- Granted patents
- 16
- Published applications
- 38
- Assignees
- 28
- Inventors
- 108
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 1 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 5 |
| 2017 | 0 | 2 |
| 2018 | 1 | 3 |
| 2019 | 1 | 0 |
| 2020 | 2 | 2 |
| 2021 | 2 | 4 |
| 2022 | 1 | 5 |
| 2023 | 2 | 6 |
| 2024 | 1 | 2 |
| 2025 | 2 | 3 |
| 2026 | 3 | 6 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Acellular dermal matrix for skin and surgical reconstruction and methods of making same28 Jul 2026US 12,691,202 B1Humabiologics, Inc.
- Fragmentation of DNA26 May 2026US 12,637,712 B2New England Biolabs, Inc.
- CRISPR/Cpf1 systems and methods5 May 2026US 12,618,054 B2Integrated Dna Technologies, Inc.
- Double tagged Serratia Marcescens nuclease7 Oct 2025US 12,435,319 B2AbClonal Science, Inc.
- Method for purifying antibody or antibody-like molecule18 Mar 2025US 12,252,510 B2Kaneka Corporation
- Systems and methods using nucleases modified with halogenated amino acids24 Sep 2026US 2026/0286327 A1Colorado State University Research Foundation
- Methods of Isolating Poxviruses from Avian Cell Cultures27 Aug 2026US 2026/0248906 A1Bavarian Nordic A/S
- Fragmentation of DNA20 Aug 2026US 2026/0242865 A1New England Biolabs, Inc.
- Engineered nuclease with high salt tolerance30 Jul 2026US 2026/0218142 A1Wuxi Biologics Ireland Limited
- CRISPR/CPF1 Systems and Methods9 Apr 2026US 2026/0098249 A1Integrated Dna Technologies, Inc.
Most cited
By later US patents
- Method for specifically cleaving double-stranded DNA and kit for the method7US 6,541,226 B1Aisin Seiki Kabushiki Kaisha · 2003
- Methods for increasing CAS9-mediated engineering efficiency7US 9,970,030 B2Caribou Biosciences, Inc. · 2018
- Method of treating a fabric4US 10,513,671 B2The Procter & Gamble Company · 2019
- Thermolabile Serratia Marcescens nuclease4US 10,920,202 B1AbClonal Science, Inc. · 2021
- Fabric softening compositions comprising an esterquat and bacterial nuclease enzyme2US 10,723,976 B2The Procter & Gamble Company · 2020